Beta-cell Responsiveness to the Incretin Hormones (Aim1)

Description

The goal of the study extension is to see whether the incretin hormone GIP increases insulin secretion in individuals with CF and normal glucose tolerance compared to individuals without CF and normal glucose tolerance. This study includes 3 or 4 visits.

For More Information

Contact Us Online

Call 267-426-5135